Cargando…

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway

The prevalence of upper tract urothelial carcinoma (UTUC) in Taiwan is relatively higher than thatin Western countries. Aristolochic acid (AA), which is widely used in traditional Chinese herbology, is now recognized to be one of the carcinogens for UTUC. Numerous UTUC patients have chronic kidney d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, I-Hsuan, Luo, Hao-Lun, Su, Yu-Li, Huang, Chun-Chieh, Chiang, Po-Hui, Yu, Chia-Cheng, Lee, Nai-Lun, Lin, Jen-Jie, Sung, Ming-Tse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832650/ https://www.ncbi.nlm.nih.gov/pubmed/31619002 http://dx.doi.org/10.3390/molecules24203707

Ejemplares similares

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2019)

Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2021)

Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
por: Boot, Arnoud, et al.
Publicado: (2020)

VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2023)

Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features
por: Luo, Hao Lun, et al.
Publicado: (2016)

The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
por: Chang, Yin Lun, et al.
Publicado: (2023)

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis
por: Liu, Hui-Ying, et al.
Publicado: (2021)

Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo
por: TAO, LE, et al.
Publicado: (2015)

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Gender Is a Significant Prognostic Factor for Upper Tract Urothelial Carcinoma: A Large Hospital-Based Cancer Registry Study in an Endemic Area
por: Huang, Chun-Chieh, et al.
Publicado: (2019)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs
por: Yang, Huang-Yu, et al.
Publicado: (2019)

The lowest level of tumor involvement is a significant prognostic factor for upper tract urothelial carcinoma after radical nephroureterectomy: A large retrospective cohort study
por: Huang, Ying-Che, et al.
Publicado: (2022)

Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study
por: Huang, Guan-Lin, et al.
Publicado: (2019)

DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma
por: Kao, Chien-Chang, et al.
Publicado: (2022)

Propensity-Matched Survival Analysis of Upper Urinary Tract Urothelial Carcinomas between End-Stage Renal Disease with and without Kidney Transplantation
por: Luo, Hao Lun, et al.
Publicado: (2019)

Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma
por: Huang, Yun-Ching, et al.
Publicado: (2023)

Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
por: Su, Yu-Li, et al.
Publicado: (2020)

Comparison of the Prognostic Value of Ki-67 and Programmed Cell Death Ligand-1 in Patients with Upper Tract Urothelial Carcinoma
por: Tsai, Mu-Yao, et al.
Publicado: (2021)

The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study
por: Chen, Tzu Shuang, et al.
Publicado: (2022)

Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma
por: Huang, Yun-Ching, et al.
Publicado: (2016)

Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan
por: Chen, I-Hsuan Alan, et al.
Publicado: (2022)

Impact of Prognostic Nutritional Index on Overall Survival for Patients with Metastatic Urothelial Carcinoma
por: Hsieh, Meng-Che, et al.
Publicado: (2018)

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer
por: Stiborová, Marie, et al.
Publicado: (2017)

Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Sheu, Zai-Lin, et al.
Publicado: (2021)

Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma
por: Su, Yu-Li, et al.
Publicado: (2017)

Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group
por: Lin, Chung-Yu, et al.
Publicado: (2022)

Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid
por: Zhu, Jie, et al.
Publicado: (2022)

Molecular Characterization of Microrna Interference and Aristolochic Acid Intoxication Found in Upper Tract Urothelial Carcinoma in Patients with Balkan Endemic Nephropathy: A Systematic Review of the Current Literature
por: Bašić, D, et al.
Publicado: (2023)

Chronic Kidney Disease and Upper Tract Urothelial Carcinomas
por: Wang, Li-Jen, et al.
Publicado: (2014)

Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells
por: Lin, Jen-Jie, et al.
Publicado: (2019)

Molecular Markers in Upper Urothelial Carcinoma Associated to Balkan Endemic Nephropathy. Aristolochic Acid as the Major Risk Factor of the Worldwide Disease
por: Jankovic Velickovic, Ljubinka, et al.
Publicado: (2009)

Management of Upper Tract Urothelial Carcinoma
por: Smith, Norm D.
Publicado: (2009)

Genetic Interference of FGFR3 Impedes Invasion of Upper Tract Urothelial Carcinoma Cells by Alleviating RAS/MAPK Signal Activity
por: Huang, Gong-Kai, et al.
Publicado: (2023)

MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells
por: Chung, Yueh-Hua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h3pdnodutjkvbb6aqf1k8mcaog